The clinical trials below are available in the specialty you selected. Choose a different specialty.

A Prospective Randomized Phase III Translational NIH Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
This study seeks adult cancer patients to determine if a daily injection of a blood-thinner, dalteparin, for three months can safely and effectively reduce the frequency of blood clots in patients at increased risk. (REF# 11739)